Addex Appoints Dr. Graham Dixon as Chief Scientific Officer and Head of Research

Addex to Present Phase 2a Dipraglurant Data at Movement Disorder Society’s International Congress

Addex Partner to Initiate Phase 2 Clinical Trial of ADX71149 for the Treatment of Major Depressive Disorder with Anxiety Symptoms

Addex Shareholders Approve All Board Proposals at Annual General Meeting

Addex Reports Positive Preclinical Data for GABA-BR PAM Oral Small Molecule in Overactive Bladder

Addex Takes Steps to Rightsize Operations and Position the Company for Future Success

Addex changes name to Addex Therapeutics

Addex Reports Positive Top Line Phase IIa Data for Dipraglurant in Parkinson's Disease Levodopa-Induced Dyskinesia (PD-LID)

Addex Pharmaceuticals Reports 2011 Financial Results

Addex Pharmaceuticals 2011 Financial Results this Thursday